Science-Backed Treatment options, including GLP-1 medications, are FDA-approved for type 2 diabetes and have proven effective for weight loss
Assessments are conducted online and are available for individuals residing in Florida, Washington, DC, New Jersey, Connecticut, and Delaware
The resulting data was pre-processed by elimination of proteins that are non-specifically bound and residual background proteins, such as common contaminants and reverse database proteins
One meta-analysis focused primarily on AEs
Keywords: BMI, GLP-1 agonists, headache, idiopathic intracranial hypertension (IIH), meta-analysis Plain language summary Can a type of diabetes and weight-loss drug help with idiopathic intracranial hypertension (IIH)